Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21161 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2024-02-10 (rheintaler.ch)
Sentiment on the stock market is mixed: the stock market is languishing
While the US stock exchanges continue their hunt for records, the Swiss stock market is languishing. The annual financial statements are mixed.
Read more
2023-09-13 (defenseworld.net)
Physicians Financial Services Inc. Decreases Stock Position in Novartis AG (NYSE:NVS)
Physicians Financial Services Inc. cut its position in Novartis AG (NYSE:NVS – Free Report) by 0.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Read more
2023-03-26 (defenseworld.net)
Dynamic Advisor Solutions LLC Sells 645 Shares of Novartis AG (NYSE:NVS)
Dynamic Advisor Solutions LLC lowered its stake in shares of Novartis AG (NYSE:NVS – Get Rating) by 13.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Read more
2023-03-22 (defenseworld.net)
North Star Investment Management Corp. Sells 598 Shares of Novartis AG (NYSE:NVS)
North Star Investment Management Corp. cut its holdings in Novartis AG (NYSE:NVS – Get Rating) by 30.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
Read more
2020-06-25 (justice.gov)
Novartis Hellas S.A.C.I. and Alcon Pte Ltd Agree to Pay over $233 Million Combined to Resolve Criminal FCPA Cases
Novartis Hellas S.A.C.I. ( Novartis Greece), a subsidiary of Novartis AG, a Switzerland-based global pharmaceutical company, and Alcon Pte Ltd, a former subsidiary of Novartis AG and current subsidiary of Alcon Inc., a multinational eye care company, have agreed to pay a combined total of more than$
Read more
2019-08-26 (ndtv.com)
Compare Novartis with Peers on Key Fundamentals and Financials - NDTV
Peers Comparison page helps you compare Novartis with its sector peers on key fundamentals, financial statements and yearly results. To find out how the performance measures up with its peers select the companies that you want to compare and click
Read more
(finanznachrichten.de)
Novartis Pharma AG: Sandoz publishes supplement to the listing prospectus, including Sandoz's financial statements for the first half of 2023
Ad hoc announcement in accordance with Art. 53 LR Supplement from Sandoz published before the Extraordinary General Meeting of Novartis on September 15, 2023The results of the first half of the year showed a
Read more
(finanznachrichten.de)
Novartis Pharma AG: Sandoz publishes supplement to the listing prospectus, including Sandoz's financial statements for the first half of 2023
Ad hoc announcement in accordance with Art. 53 LR Supplement from Sandoz published before the Extraordinary General Meeting of Novartis on September 15, 2023The results of the first half of the year showed a
Read more
(ariva.de)
EQS-GM: MorphoSys AG: Announcement of the convening of the Annual General Meeting on May 17, 2023 in Planegg with the aim of disseminating it throughout Europe in accordance with Section 121 AktG (10619172) - April 4, 2023 - News - ARIVA.DE
Message: EQS-GM: MorphoSys AG: Announcement of the convening of the Annual General Meeting on May 17, 2023 in Planegg with the aim of disseminating it throughout Europe in accordance with Section 121 AktG (10619172) - April 4, 2023 - News
Read more